Position in PRPO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$272
-$3 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 18 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRPO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $3,428,308,964 across 38 Diagnostics & Research names. PRPO ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,430,798 | $1,720,064,877 | |
| 2 | DHR |
Danaher Corp /De/
|
2,393,859 | $455,982,255 | |
| 3 | LH |
Labcorp Holdings Inc.
|
807,619 | $226,133,320 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
797,956 | $154,181,053 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
274,340 | $144,423,545 | |
| 6 | A |
Agilent Technologies, Inc.
|
835,556 | $110,986,898 | |
| 7 | WAT |
Waters Corp /De/
|
267,531 | $100,334,819 | |
| 8 | NTRA |
Natera, Inc.
|
295,159 | $80,120,905 |
All Filings in PRPO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $272 | 11 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $275 | 11 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $252 | 11 | Shares | Defined | 2026-02-17 | |
| 2020-09-30 | $122 | 50 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $193 | 136 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $95 | 136 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||